ENTRY REQUIREMENTS
Specialist/master’s degrees in Pharmacy and Industrial Pharmacy (14/S or LM-13);
Medical, Veterinary, and Pharmaceutical Biotechnology (9/S or LM-9); Industrial Biotechnology (8/S or LM8); Chemical Engineering (27/LM-22 or 27/S), and Chemical Sciences (LM-54 or 62/S).
Degrees prior to DM 509/99 in Chemistry and Pharmaceutical Technology or Pharmacy, Agro-industrial Biotechnology, Biotechnology curriculum Pharmaceutical Biotechnology, Biotechnology curriculum Industrial Biotechnology, Biotechnology curriculum Medical Biotechnology, Biotechnology curriculum Veterinary Biotechnology, Chemical Engineering, and Chemistry.

Professional profile that the Master Programme intends to train:
Over the last decade, radical changes in products developed and marketed by the
biopharmaceutical industry, as well as a growing interest in improving the efficiency and
effectiveness of production, have encouraged an evolution in the technologies and processes
in use to produce the latest generation of biopharmaceutical products.
The aim of the Master is to train experts able to manage the different processes of industrial
development of laboratories with biotechnological and pharmacological characterization, to
respond to the growing demand for highly qualified operators from companies and institutions
in the sector.
The master aims to prepare specialized personnel with a high level of qualification, able to cover
various professional positions within the biopharmaceutical drugs world. These professionals will
be qualified as:
• Manager/Director of laboratories with biotechnological and pharmacological
characterization.
• Coordinator of development and monitoring programs of applied biotechnologies in the
human health, regarding the industrial development of biopharmaceutical products, the
industrial aspects of biotechnological drugs production, the management of scientific and
process related data with artificial Intelligence (AI).
• Expert in management of the regulatory aspects of the market authorizations, of the
ethical and legal implications of the marketing of biopharmaceuticals with aspects of
environmental protection and sustainability.